Older adults' adherence to medications and willingness to deprescribe: A substudy of a randomized clinical trial

Br J Clin Pharmacol. 2024 Mar;90(3):905-911. doi: 10.1111/bcp.15966. Epub 2023 Dec 7.

Abstract

Our study investigated the association between patients' willingness to have medications deprescribed and medication adherence. This longitudinal substudy of the 'Optimizing PharmacoTherapy In the Multimorbid Elderly in Primary CAre' (OPTICA) trial, a cluster randomized controlled trial, took place in Swiss primary care settings. Participants were aged ≥65 years and over, with ≥3 chronic conditions and ≥5 regular medications. At baseline, the 'revised Patient Attitudes Towards Deprescribing' (rPATD) questionnaire was measured. The A14-scale measured adherence (self-report) at the 12-month follow-up. Multilevel linear regression analyses adjusted for baseline variables were performed. Of the 298 participants, 45% were women, and the median age was 78. Participants reported a high level of adherence and willingness to have medications deprescribed. We did not find evidence for an association between patients' willingness to deprescribe and medication adherence. Further research is needed to explore the relationship between these concepts and to inform collaborative decisions about medicines in the context of polypharmacy.

Keywords: comorbidity; deprescribing; patient attitudes; polypharmacy; prescription.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Deprescriptions*
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Multimorbidity
  • Polypharmacy
  • Self Report
  • Surveys and Questionnaires